Century Therapeutics Stock Forecast - Accumulation Distribution
| IPSC Stock | USD 2.40 0.02 0.83% |
Century Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Century Therapeutics stock prices and determine the direction of Century Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Century Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
The RSI of Century Therapeutics' share price is above 70 at the present time. This usually indicates that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Century, making its price go up or down. Momentum 74
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.33) | EPS Estimate Current Year (0.13) | EPS Estimate Next Year (0.97) | Wall Street Target Price 3.5 | EPS Estimate Current Quarter (0.39) |
Using Century Therapeutics hype-based prediction, you can estimate the value of Century Therapeutics from the perspective of Century Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Century Therapeutics using Century Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Century using crowd psychology based on the activity and movement of Century Therapeutics' stock price.
Century Therapeutics Implied Volatility | 1.0 |
Century Therapeutics' implied volatility exposes the market's sentiment of Century Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Century Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Century Therapeutics stock will not fluctuate a lot when Century Therapeutics' options are near their expiration.
Century Therapeutics after-hype prediction price | USD 2.23 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Century Therapeutics to cross-verify your projections. Open Interest Against 2026-04-17 Century Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Century Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Century Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Century Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Century Therapeutics' open interest, investors have to compare it to Century Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Century Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Century. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Century Therapeutics Additional Predictive Modules
Most predictive techniques to examine Century price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Century using various technical indicators. When you analyze Century charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Century Therapeutics Volatility | Backtest Century Therapeutics | Information Ratio |
Century Therapeutics Trading Date Momentum
| On January 26 2026 Century Therapeutics was traded for 2.40 at the closing time. The top price for the day was 2.58 and the lowest listed price was 2.08 . There was no trading activity during the period 0.0. Lack of trading volume on January 26, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.83% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Century Therapeutics to competition |
Other Forecasting Options for Century Therapeutics
For every potential investor in Century, whether a beginner or expert, Century Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Century Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Century. Basic forecasting techniques help filter out the noise by identifying Century Therapeutics' price trends.Century Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Century Therapeutics stock to make a market-neutral strategy. Peer analysis of Century Therapeutics could also be used in its relative valuation, which is a method of valuing Century Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Century Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Century Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Century Therapeutics shares will generate the highest return on investment. By undertsting and applying Century Therapeutics stock market strength indicators, traders can identify Century Therapeutics entry and exit signals to maximize returns.
Century Therapeutics Risk Indicators
The analysis of Century Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Century Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting century stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.81 | |||
| Semi Deviation | 4.52 | |||
| Standard Deviation | 9.18 | |||
| Variance | 84.21 | |||
| Downside Variance | 43.33 | |||
| Semi Variance | 20.43 | |||
| Expected Short fall | (7.90) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Century Therapeutics
The number of cover stories for Century Therapeutics depends on current market conditions and Century Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Century Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Century Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Century Therapeutics Short Properties
Century Therapeutics' future price predictability will typically decrease when Century Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Century Therapeutics often depends not only on the future outlook of the potential Century Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Century Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 78.6 M | |
| Cash And Short Term Investments | 189.3 M |
Check out Historical Fundamental Analysis of Century Therapeutics to cross-verify your projections. For information on how to trade Century Stock refer to our How to Trade Century Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Century Therapeutics. If investors know Century will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Century Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.32) | Revenue Per Share | Quarterly Revenue Growth 126.677 | Return On Assets | Return On Equity |
The market value of Century Therapeutics is measured differently than its book value, which is the value of Century that is recorded on the company's balance sheet. Investors also form their own opinion of Century Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Century Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Century Therapeutics' market value can be influenced by many factors that don't directly affect Century Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Century Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Century Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Century Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.